Stage II Hypopharyngeal Carcinoma AJCC v8

specific

Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. N0: No regional lymph node metastasis. N1

28

Centers

28

Active Trials

Cancer Funding

Top Centers for Stage II Hypopharyngeal Carcinoma AJCC v8(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.8
2
NCI Comprehensive
Active Research Program
51.8
3
NCI Comprehensive
Active Research Program
51.8
4
NCI Comprehensive
Active Research Program
51.8
551.8
6
NCI Comprehensive
Active Research Program
51.8
7
NCI Comprehensive
Active Research Program
51.8
8
NCI Comprehensive
Active Research Program
51.8
9
NCI Comprehensive
Active Research Program
51.8
10
NCI Comprehensive
Active Research Program
51.8
11
NCI Comprehensive
Active Research Program
51.8
12
Active Research Program
51.8
13
NCI Comprehensive
Active Research Program
51.8
14
Active Research Program
51.8
15
NCI Comprehensive
Active Research Program
51.8
16
NCI Comprehensive
Active Research Program
51.8
17
NCI Comprehensive
Active Research Program
51.8
18
NCI Comprehensive
Active Research Program
51.8
19
Active Research Program
51.8
20
NCI Comprehensive
Active Research Program
51.8
21
Active Research Program
51.8
22
Active Research Program
51.8
23
NCI Comprehensive
Active Research Program
51.8
24
Active Research Program
51.8
25
Active Research Program
51.8
26
Active Research Program
51.8
27
Active Research Program
51.8
28
Active Research Program
51.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →